OUR TECHNOLOGY
CDMO Services

siRNA development services

There is a growing demand for oligonucleotides as drugs and for other uses, due to their broad spectrum.

We provide specific and customized services:

  • Development of RNAi-based components for a wide range of targets.
  • Oligonucleotide-based drugs for new or existing therapies.

We take care of the complete drug development cycle:

Capabilities

  • Manufacturing at all scales
  • Annual manufacturing capacity up to 1 Kg
  • Areas dedicated to preclinical manufacturing
  • A wide range of synthesis chemistries and modifications.
  • Established synthesis platforms for long and complex oligonucleotides
  • Customized processes
  • High quality raw materials from selected suppliers
  • Optimized and controlled manufacturing processes carried out by highly qualified and trained professionals
  • Continuous monitoring of in-process controls and final products by our Quality Control Department, which uses state-of-the-art technologies to analyze oligonucleotides